GlassScriptPhysician profile
Katherine Kottwitz
NPI 1194130948
$8,068.65
in general payments reported to CMS, 2019-2025
13 companies · $4,949 in 2025
The $4,949 reported for 2025 was more than what 92% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2021: $960 · 2022: $885 · 2023: $369 · 2024: $365 · 2025: $4,949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,487 · Food and Beverage: $2,016 · Travel and Lodging: $1,093 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,486.92 |
| Food and Beverage | $2,016.13 |
| Travel and Lodging | $1,092.86 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $4,512.60 | 2025 | |
| Sientra, INC. | $900.46 | 2021-2022 | |
| Allergan, INC. | $552.77 | 2021-2022 | |
| Merz North America, INC. | $439.30 | 2021-2025 | Xeomin |
| Wardlow Enterprises | $385.00 | 2019 | |
| Revance Therapeutics, INC. | $358.63 | 2024-2025 | Daxxify |
| Mentor Worldwide LLC | $355.19 | 2021-2025 | Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $325.48 | 2023-2024 | |
| Tepha INC | $82.09 | 2019 | |
| Checkpoint Surgical, INC | $73.98 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $42.16 | 2021-2022 | |
| Galderma Laboratories, L.P. | $25.91 | 2021-2022 | |
| Kci USA, INC. | $15.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Kottwitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.